News Focus
News Focus
Followers 210
Posts 32730
Boards Moderated 1
Alias Born 06/30/2009

Re: rrr1 post# 288125

Tuesday, 03/24/2020 11:43:55 AM

Tuesday, March 24, 2020 11:43:55 AM

Post# of 405171
"Was it Brilacidin or Kevatrin that they applied to BARDA for."

"Innovation Pharmaceuticals has submitted a preliminary summary of Brilacidin’s therapeutic potential as a novel coronavirus treatment to the U.S. Government’s Biomedical Advanced Research and Development Authority (BARDA) and is already collaborating with scientists at the National Institute of Allergy and Infectious Diseases (NIAID) for review of Brilacidin as a potential COVID-19 intervention."

Not sure what they sent was an application.

I drink blue juice from under the sink!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y